Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture.
Wang X, Sacramento CQ, Jockusch S, Chaves OA, Tao C, Fintelman-Rodrigues N, Chien M, Temerozo JR, Li X, Kumar S, Xie W, Patel DJ, Meyer C, Garzia A, Tuschl T, Bozza PT, Russo JJ, Souza TML, Ju J.
Wang X, et al. Among authors: li x.
Commun Biol. 2022 Feb 22;5(1):154. doi: 10.1038/s42003-022-03101-9.
Commun Biol. 2022.
PMID: 35194144
Free PMC article.